Intraductal Papillary Mucinous Neoplasm of the Pancreas
📧 Sign up to get email alerts when something new happens for Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
A clinical trial is actively recruiting to evaluate AI-based management of pancreatic cystic lesions using endoscopic ultrasound and multimo…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) [Phase 4]
Phase 4 clinical trial evaluating a perioperative bundle including hydrocortisone, octreotide, and a teres ligament patch to reduce postoper…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium
This clinical trial update describes the INCITE consortium's plan to integrate multiomics markers to identify invasive intraductal papillary…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3) [Phase 2]
This Phase 2 clinical trial update reports Tocotrienol (SIPP-T3) being studied to prevent progression of intraductal papillary mucinous neop…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
A clinical trial update describing an imaging and biomarker study for early detection of pancreatic cancer in patients with intraductal papi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) [Phase 2]
Phase 2 clinical trial update from Duke University on preventing progression from intraductal papillary mucinous neoplasm to pancreatic canc…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Impact of GLP-1 Receptor Agonists on Patients With IPMN
A clinical trial is evaluating the impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasm of the pancrea…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts [NA]
A feasibility study evaluating endoscopic ultrasound-guided pancreatic cyst ablation (EUS-PCA) for intraductal papillary mucinous neoplasms …
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
This is a clinical trial update describing the LINFU U.S. Registry for patients with intraductal papillary mucinous neoplasm (IPMN) of the p…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas
Clinical trial NCT06706700 is evaluating endocrine, metabolic, and inflammatory biomarkers to identify high-grade dysplasia or invasive carc…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia. [Phase 3]
Phase 3 clinical trial examining aspiration methods for molecular analysis in intraductal papillary mucinous neoplasm of the pancreas.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: 18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas [NA]
Completed clinical trial evaluating 18-FDG PET-CT for diagnosing degeneration in intraductal papillary mucinous neoplasm of the pancreas.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 study of erlotinib in pancreatic cancer that can be removed by surgery was terminated; results have been posted.